Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty

Status Completed

Clinical Trial Summary

Background: Despite the excellent results of total knee replacement, also known as total knee arthroplasty (TKA) there is persistent controversy over whether or not to replace the surface of the kneecap. Anterior knee pain, which occurs with variable and unpredictable frequency, continues to be a problem in a subset of TKA patients. Some clinicians replace the surface of all kneecaps during TKA to avoid repeat surgery, which occurs in approximately 10% of cases. However, others cite the complications attributed to replacing the surface of kneecap as reasons to avoid this procedure. This study prospectively randomized patients receiving TKA into two groups, those receiving replacement of the kneecap surface and those left without replacement of the kneecap surface to determine clinical outcomes and revisions over the first 5-10 postoperative years. Objectives: The primary objective of this work was to compare pain, stiffness and function between groups at five years postoperatively. Secondarily, we compared pain, stiffness and function at one and 10 years postoperatively. Finally, we examined the number of reoperations following TKR over 10 years in the 2 groups of subjects. The investigators hypothesized that there would be no difference between the two groups of subjects in the measured outcomes. Methods: Patients receiving TKA were prospectively enrolled before surgery and randomized intraoperatively to either receive a replacement of the kneecap surface or have no kneecap intervention. The Smith and Nephew Profix TKA system was implanted in all cases; the post-operative regimen was standardized. Subjects were assessed pre-operatively and at 1 and 5 years postoperatively for pain, function, and stiffness using a disease-specific (Western Ontario and MacMaster Osteoarthritis Index [WOMAC]) and generic health status (Short Form 36 [SF-36]) questionnaire. At the end of the five year follow-up, the study was extended to a 10-year followup and the same outcomes were assessed. The revision rate was also compared between the two groups at the end of the 10-year follow-up.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Total Knee Replacement

Clinical Trial Details

NCT number	NCT01500252
Study type	Interventional
Source	University of Alberta
Contact
Status	Completed
Phase	Phase 4
Start date	September 1996
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04040985` - Legion Primary Safety and Efficacy	N/A
Recruiting	`NCT05279092` - Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study	Phase 2
Completed	`NCT03286543` - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System	N/A
Not yet recruiting	`NCT04594447` - Physica System KR vs Physica System CR (K-20)	N/A
Completed	`NCT02413996` - Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty	N/A
Completed	`NCT04081493` - The Efficacy of Low-load Blood Flow Restricted Resistance Before TKR	N/A
Active, not recruiting	`NCT03339557` - Comparison of Three Knee Replacements	N/A
Enrolling by invitation	`NCT04513145` - Adductor Canal Block	Phase 2/Phase 3
Completed	`NCT06045078` - Aromatherapy in Total Knee Replacement	N/A
Completed	`NCT02468934` - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Using the SPRINT System	N/A
Completed	`NCT02914210` - Virtual vs. Traditional Physical Therapy Following Total Knee Replacement	N/A
Withdrawn	`NCT01523418` - Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)	N/A
Completed	`NCT00795223` - Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA	Phase 4
Completed	`NCT01307202` - Morphine Consumption in Joint Replacement Patients, With or Without Gabapentin Treatment	N/A
Completed	`NCT01522781` - 10 Year Outcome of Total Knee Replacement (TKR) Using Sigma Prosthesis	N/A
Completed	`NCT01515449` - Predictors of Poor Outcomes in 1038 Sigma Knees	N/A
Completed	`NCT04166539` - Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty
Completed	`NCT03454256` - Virtual Reality Rehabilitation in Patients With Total Knee Replacement	N/A
Enrolling by invitation	`NCT06118073` - Effect of Mindfulness on Pain After Total Knee Arthroplasty	N/A
Completed	`NCT05597046` - Qualitative Interviews With Healthcare Professionals

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty - A Randomized Clinical Trial — PROFIX

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms